ABSTRACT
Consistent with this hypothesis is the work of Carlson et al. (9) who reported a reduced incidence of NEC in infants fed a preterm formula supplemented with egg phospholipids. The supplemented formula contained 0.4% of total fatty acids as ARA and 0.13% of total fatty acids as docosahexaenoic acid (DHA). The incidence of NEC in infants receiving the supplemented formula was 2.9%, compared with 17.6% in the control group.
